Scope Fluidics Spolka Akcyjna's quarterly market cap
increased
from Sep. 2025 (€92.28 Mil) to Dec. 2025 (€118.64 Mil) but then
declined
from Dec. 2025 (€118.64 Mil) to Mar. 2026 (€90.29 Mil).
Scope Fluidics Spolka Akcyjna's annual market cap
increased
from Dec. 2023 (€113.13 Mil) to Dec. 2024 (€116.26 Mil) and
increased
from Dec. 2024 (€116.26 Mil) to Dec. 2025 (€118.64 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Scope Fluidics Spolka Akcyjna's Enterprise Value for Today is €55.92 Mil.
Scope Fluidics Spolka Akcyjna (FRA:S84) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Scope Fluidics Spolka Akcyjna Market Cap Related Terms
Scope Fluidics Spolka Akcyjna Market Cap Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Diagnostics & Research subindustry, Scope Fluidics Spolka Akcyjna's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Scope Fluidics Spolka Akcyjna Market Cap vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Scope Fluidics Spolka Akcyjna's Market Cap distribution charts can be found below:
* The bar in red indicates where Scope Fluidics Spolka Akcyjna's Market Cap falls into.
Scope Fluidics Spolka Akcyjna Market Cap Calculation
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Scope Fluidics Spolka Akcyjna (FRA:S84) has a Market Cap of €87.62 Mil as of Jul. 01, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Scope Fluidics Spolka Akcyjna and its competitors. According to the industry distribution chart, Scope Fluidics Spolka Akcyjna ranks #97 out of 218 companies in the Medical Diagnostics & Research industry, placing it in the top 44.5%.
Is Scope Fluidics Spolka Akcyjna's Market Cap too high?
Scope Fluidics Spolka Akcyjna's current Market Cap is €87.62 Mil. Based on the distribution chart, Scope Fluidics Spolka Akcyjna ranks #97 out of 218 companies in the Medical Diagnostics & Research industry, which is above the industry midpoint. Overall, Scope Fluidics Spolka Akcyjna has a GF Score™ of 45/100, reflecting its overall financial health beyond just this single metric.
How does Scope Fluidics Spolka Akcyjna's Market Cap compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, Scope Fluidics Spolka Akcyjna ranks #97 out of 218 companies for Market Cap. This puts Scope Fluidics Spolka Akcyjna in the upper half of its industry. The industry median Market Cap is 58.23. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Medical Diagnostics & Research company?
The median Market Cap among Medical Diagnostics & Research companies is 58.23, based on 218 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Scope Fluidics Spolka Akcyjna and its competitors. For the Medical Diagnostics & Research industry, the median Market Cap is 58.23 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Scope Fluidics Spolka Akcyjna's current Market Cap is €87.62 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Scope Fluidics Spolka Akcyjna stock overvalued right now?
Scope Fluidics Spolka Akcyjna (FRA:S84) has a current Market Cap of €87.62 Mil. The stock's GF Value™ is €26.71, compared to a current price of €23.50 — trading 12% below its estimated fair value. The current Market Cap is €87.62 Mil. Scope Fluidics Spolka Akcyjna's overall GF Score™ is 45/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Scope Fluidics Spolka Akcyjna (FRA:S84), the current Market Cap is €87.62 Mil as of Jul. 01, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Scope Fluidics Spolka Akcyjna (FRA:S84) Overvalued in 2026?
Based on GuruFocus' analysis, Scope Fluidics Spolka Akcyjna stock appears to be undervalued.
The current stock price of €23.50 is trading 12% below its estimated GF Value™ of €26.71.
Key valuation signals for FRA:S84:
Market Cap: €87.62 Mil
GF Value™: €26.71 vs. price of €23.50 (12% below fair value)
No single metric tells the full story. See the FRA:S84 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Scope Fluidics Spolka Akcyjna Business Description
Scope Fluidics Spolka Akcyjna focuses on global challenges in health to develop diagnostic and med tech solutions. The company combines the expertise in microfluidic technology with the awareness of the challenges in medical diagnostics. It provides prototyping support for diagnostic services.
45GF Score
Get the complete analysis for FRA:S84
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:S84 has been successfully added to your 
